Need professional-grade analysis? Visit stockanalysis.com
$1.17B
N/A
3,100
7.39%
Kindstar Globalgene Tech Inc (9960) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at HKD1.23, up 3.36% from the previous close.
Over the past year, 9960 has traded between a low of HKD1.05 and a high of HKD1.71. The stock has lost 1.3% over this period. It is currently 28.1% below its 52-week high.
Kindstar Globalgene Tech Inc has a market capitalization of $1.17B and a dividend yield of 7.39%.
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. The company was founded in 2003 and is headquartered in Wuhan, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.